Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation

J Cell Mol Med. 2022 Feb;26(4):1327-1331. doi: 10.1111/jcmm.17136. Epub 2021 Dec 24.

Abstract

The microtubule-associated protein tau gene (MAPT) 10+16 intronic mutation causes frontotemporal lobar degeneration (FTLD) by increasing expression of four-repeat (4R)-tau isoforms. We investigated the potential role for astrocytes in the pathogenesis of FTLD by studying the expression of 4R-tau. We derived astrocytes and neurons from induced pluripotent stem cells from two asymptomatic 10+16 carriers which, compared to controls, showed persistently increased 4R:3R-tau transcript and protein ratios in both cell types. However, beyond 300 days culture, 10+16 neurons showed less marked increase of this 4R:3R-tau transcript ratio compared to astrocytes. Interestingly, throughout maturation, both 10+16 carriers consistently displayed different 4R:3R-tau transcript and protein ratios. These elevated levels of 4R-tau in astrocytes implicate glial cells in the pathogenic process and also suggests a cell-type-specific regulation and may inform and help on treatment of pre-clinical tauopathies.

Keywords: 4R-tau; astrocytes; frontotemporal dementia; frontotemporal lobar degeneration; pluripotent stem cells; tauopathies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Astrocytes / metabolism
  • Frontotemporal Lobar Degeneration*
  • Humans
  • Mutation / genetics
  • Protein Isoforms / genetics
  • Tauopathies* / genetics
  • Tauopathies* / metabolism
  • tau Proteins* / genetics
  • tau Proteins* / metabolism

Substances

  • MAPT protein, human
  • Protein Isoforms
  • tau Proteins